• Nearly 40% of IPF Patients in US Not Prescribed Esbriet or Ofev Despite Effectiveness, Study Reports
  • Face-to-Face from Far Away: Tech to Help Weather the Wait
  • Paragonix’s LUNGguard System Cleared by FDA for Use in Transporting Donor Lungs
  • Bernadette Peters Joins Other Broadway Stars for 10th Annual PFF Fundraiser
  • Living Life in Incremental Steps: Sports, Cleveland, and Happiness
  • The Reasons I Socially Isolate Myself
  • Reducing the Decline in Patients’ Forced Vital Capacity Can Lower Mortality Rates and Healthcare Burden in IPF, Study Says
  • FDA Efforts to Bring Patients into Treatment Decisions Focus of NORD Webinar
  • Negotiating with My Emotional Self: Internal Struggles of an IPF Patient
  • Software May Predict IPF Progression Based on Chest Scans
  • How to Curate Compassionate Communication
  • Immune Protein SP-A Can Predict Esbriet, Ofev Therapy Outcomes in IPF Patients, Study Finds